143 related articles for article (PubMed ID: 20398761)
1. Vitamin D and primary hyperparathyroidism (PHPT).
Souberbielle JC; Maury E; Friedlander G; Cormier C
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):199-203. PubMed ID: 20398761
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D and primary hyperparathyroidism (PHPT).
Souberbielle JC; Bienaimé F; Cavalier E; Cormier C
Ann Endocrinol (Paris); 2012 Jun; 73(3):165-9. PubMed ID: 22677209
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
[TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation.
Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Silverberg SJ
J Clin Endocrinol Metab; 2015 Sep; 100(9):3443-51. PubMed ID: 26079779
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D status in primary hyperparathyroidism.
Saliba W; Lavi I; Rennert HS; Rennert G
Eur J Intern Med; 2012 Jan; 23(1):88-92. PubMed ID: 22153538
[TBL] [Abstract][Full Text] [Related]
7. Low vitamin D levels have become less common in primary hyperparathyroidism.
Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Bilezikian JP; Silverberg SJ
Osteoporos Int; 2015 Dec; 26(12):2837-43. PubMed ID: 26084258
[TBL] [Abstract][Full Text] [Related]
8. Effect of Low Vitamin D on Volumetric Bone Mineral Density, Bone Microarchitecture, and Stiffness in Primary Hyperparathyroidism.
Walker MD; Nishiyama KK; Zhou B; Cong E; Wang J; Lee JA; Kepley A; Zhang C; Guo XE; Silverberg SJ
J Clin Endocrinol Metab; 2016 Mar; 101(3):905-13. PubMed ID: 26745256
[TBL] [Abstract][Full Text] [Related]
9. Primary hyperparathyroidism and the skeleton.
Mosekilde L
Clin Endocrinol (Oxf); 2008 Jul; 69(1):1-19. PubMed ID: 18167138
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D status affects osteopenia in postmenopausal patients with primary hyperparathyroidism.
Inoue Y; Kaji H; Hisa I; Tobimatsu T; Naito J; Iu MF; Sugimoto T; Chihara K
Endocr J; 2008 Mar; 55(1):57-65. PubMed ID: 18187872
[TBL] [Abstract][Full Text] [Related]
11. Serum calcium (S-Ca), the forgotten test: preliminary results of an appropriateness strategy to detect primary hyperparathyroidism (pHPT).
Salinas M; López-Garrigós M; Pomares F; Lugo J; Asencio A; López-Penabad L; Dominguez JR; Leiva-Salinas C
Bone; 2013 Sep; 56(1):73-6. PubMed ID: 23707628
[TBL] [Abstract][Full Text] [Related]
12. Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature.
Shah VN; Shah CS; Bhadada SK; Rao DS
Clin Endocrinol (Oxf); 2014 Jun; 80(6):797-803. PubMed ID: 24382124
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of common vitamin D supplementation in primary hyperparathyroidism and coexistent vitamin D deficiency and insufficiency: a systematic review and meta-analysis.
Song A; Zhao H; Yang Y; Liu S; Nie M; Wang O; Xing X
J Endocrinol Invest; 2021 Aug; 44(8):1667-1677. PubMed ID: 33453021
[TBL] [Abstract][Full Text] [Related]
14. Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8 years ago.
Lundgren E; Hagström EG; Lundin J; Winnerbäck K; Roos J; Ljunghall S; Rastad J
World J Surg; 2002 Aug; 26(8):931-6. PubMed ID: 12045863
[TBL] [Abstract][Full Text] [Related]
15. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
Pierreux J; Bravenboer B
Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism.
Stein EM; Dempster DW; Udesky J; Zhou H; Bilezikian JP; Shane E; Silverberg SJ
Bone; 2011 Mar; 48(3):557-61. PubMed ID: 20950725
[TBL] [Abstract][Full Text] [Related]
17. Sclerostin and DKK1 in primary hyperparathyroidism.
Viapiana O; Fracassi E; Troplini S; Idolazzi L; Rossini M; Adami S; Gatti D
Calcif Tissue Int; 2013 Apr; 92(4):324-9. PubMed ID: 23430197
[TBL] [Abstract][Full Text] [Related]
18. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
Christiansen P
APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
[TBL] [Abstract][Full Text] [Related]
19. Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism.
Viccica G; Cetani F; Vignali E; Miccoli M; Marcocci C
Endocrine; 2017 Jan; 55(1):256-265. PubMed ID: 27033542
[TBL] [Abstract][Full Text] [Related]
20. Over-supplementation of vitamin D in two patients with primary hyperparathyroidism.
Battista C; Viti R; Minisola S; Chiodini I; Frusciante V; Scillitani A; Carnevale V
Hormones (Athens); 2013; 12(4):598-601. PubMed ID: 24457409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
